chr14-67165222-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6_Very_StrongBP7
The NM_020806.5(GPHN):āc.1971A>Cā(p.Leu657=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000453 in 1,595,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00016 ( 0 hom., cov: 32)
Exomes š: 0.00048 ( 0 hom. )
Consequence
GPHN
NM_020806.5 synonymous
NM_020806.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.122
Genes affected
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 14-67165222-A-C is Benign according to our data. Variant chr14-67165222-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 466205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-67165222-A-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.122 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPHN | NM_020806.5 | c.1971A>C | p.Leu657= | synonymous_variant | 20/23 | ENST00000478722.6 | NP_065857.1 | |
LOC105370538 | XR_007064215.1 | n.133-11372T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPHN | ENST00000478722.6 | c.1971A>C | p.Leu657= | synonymous_variant | 20/23 | 1 | NM_020806.5 | ENSP00000417901 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152196Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
24
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000239 AC: 60AN: 251086Hom.: 0 AF XY: 0.000287 AC XY: 39AN XY: 135730
GnomAD3 exomes
AF:
AC:
60
AN:
251086
Hom.:
AF XY:
AC XY:
39
AN XY:
135730
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000484 AC: 699AN: 1443720Hom.: 0 Cov.: 27 AF XY: 0.000481 AC XY: 346AN XY: 719468
GnomAD4 exome
AF:
AC:
699
AN:
1443720
Hom.:
Cov.:
27
AF XY:
AC XY:
346
AN XY:
719468
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000158 AC: 24AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74348
GnomAD4 genome
AF:
AC:
24
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | GPHN: BP4, BP7 - |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
GPHN-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 28, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at